Literature DB >> 31326830

Walking endurance in multiple sclerosis: Meta-analysis of six-minute walk test performance.

Katie L J Cederberg1, E Morghen Sikes2, Alfred A Bartolucci3, Robert W Motl4.   

Abstract

BACKGROUND: The 6-minute walk (6 MW) is the most commonly applied measure of endurance walking capacity in persons with multiple sclerosis (MS); however, we are not aware of a quantitative synthesis of 6 MW performance in MS. RESEARCH QUESTION: We undertook a meta-analysis quantifying the overall magnitude of difference in 6 MW performance between MS and healthy controls (HCs), and then within MS as a function of disability status. We further examined possible moderator variables of 6 MW performance.
METHODS: The systematic search was conducted for articles that included the 6 MW in persons with MS and involved comparison groups (i.e., HCs or MS disability subgroups (i.e., mild vs moderate-to-severe disability status)). The mean and standard deviation of the distance traveled during the 6 MW as well as sample sizes were entered into Comprehensive Meta-Analysis software and we estimated the overall effect size (Cohen's d) using a random effects model and examined categorical variables as possible moderators (e.g., instruction protocol, provision of encouragement, method of distance measurement, and course description).
RESULTS: Thirty-four studies met inclusion criteria with a total sample size of 3204 persons (MS: 2683; HC: 521) yielding 42 total comparisons. Persons with MS walked a shorter distance than HCs (mean difference = -177.2 ± 19.1 m) with a large effect size (d = - 1.87). Persons with mild disability walked further than those with moderate-to-severe disability (mean difference = 185.19 ± 9.2 m) with a large effect (d = 1.83). The categorical variables of provision of encouragement and course layout moderated the effect of MS and course layout moderated the effect of disability status on 6 MW performance. SIGNIFICANCE: This meta-analysis of 6 MW performance defines mean difference in 6 MW performance in MS compared with HCs and provides an estimate of the disease-related effect of MS on endurance walking capacity for application within clinical research and practice.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Endurance walking capacity; Multiple sclerosis; Six-minute walk test

Year:  2019        PMID: 31326830     DOI: 10.1016/j.gaitpost.2019.07.125

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  8 in total

1.  Acute Thermoregulatory and Cardiovascular Response to Submaximal Exercise in People With Multiple Sclerosis.

Authors:  Elisa Gervasoni; Rita Bertoni; Denise Anastasi; Claudio Solaro; Rachele Di Giovanni; Erica Grange; Hanns-Christian Gunga; Marco Rovaris; Davide Cattaneo; Martina Anna Maggioni; Giampiero Merati
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

2.  Sex-Based Differences in Oxygen Cost of Walking and Energy Equivalents in Minimally Disabled Individuals With Multiple Sclerosis and Controls.

Authors:  Andrea Manca; Antonella Cano; Lucia Ventura; Gianluca Martinez; Lior Frid; Franca Deriu; Alon Kalron
Journal:  Int J MS Care       Date:  2021-07-27

3.  Reliability of the six-minute walk test in individuals with stroke: systematic review and meta-analysis.

Authors:  Alice Macchiavelli; Antonella Giffone; Francesco Ferrarello; Matteo Paci
Journal:  Neurol Sci       Date:  2020-10-16       Impact factor: 3.307

4.  Cognitive Processing Speed Impairment Does Not Influence the Construct Validity of Six-Spot Step Test Performance in People With Multiple Sclerosis.

Authors:  Brian M Sandroff; Stephanie L Silveira; Jessica F Baird; Trinh Huynh; Robert W Motl
Journal:  Phys Ther       Date:  2021-02-04

5.  Comparing the use of mathematical calculation to a measuring wheel to determine distance walked in three different course configurations of the 6 minute Walk Test in healthy adults.

Authors:  Suzanne K O'Neal; Megan C Eikenberry; Alexander Bocchi; Kyle Carroll; Michelle Fettig; Parker Folliard; Clara Martinez
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

Review 6.  The pathophysiology of motor fatigue and fatigability in multiple sclerosis.

Authors:  Robert Patejdl; Uwe K Zettl
Journal:  Front Neurol       Date:  2022-07-27       Impact factor: 4.086

7.  Measuring Outdoor Walking Capacities Using Global Positioning System in People with Multiple Sclerosis: Clinical and Methodological Insights from an Exploratory Study.

Authors:  Coralie Delahaye; Dorine Chaves; Florian Congnard; Bénédicte Noury-Desvaux; Pierre-Yves de Müllenheim
Journal:  Sensors (Basel)       Date:  2021-05-04       Impact factor: 3.576

Review 8.  Outcome measures assisting treatment optimization in multiple sclerosis.

Authors:  Gabriel Pardo; Samantha Coates; Darin T Okuda
Journal:  J Neurol       Date:  2021-08-02       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.